Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how?
AsiaIntervention 2022;8:24-31
Towards a common pathway for the treatment of left main disease: contemporary evidence and future directions
AsiaIntervention 2021;7:85-95